Health officials have announced a significant expansion of the meningitis B vaccination programme to include Year 11 pupils at schools impacted by the ongoing outbreak in Kent. This move comes as the latest figures from the UK Health Security Agency reveal a notable decline in confirmed cases.
Declining Case Numbers and Vaccination Rollout
As of Monday afternoon, the UKHSA reported 20 confirmed cases of meningitis B, with an additional three under investigation, bringing the total to 23. This represents a decrease from the 29 cases reported on Sunday, which included 20 confirmed and nine under investigation. The vaccination initiative initially targeted University of Kent students, commencing on Wednesday, 18 March.
Expansion to Schools and Precautionary Measures
During a campus visit the following day, Health Secretary Wes Streeting confirmed the programme would be broadened to encompass more individuals, specifically sixth form pupils at four schools with known or suspected cases. Ministers have since agreed to extend this offer to Year 11 pupils at these institutions as a precautionary step to ensure long-term protection against the disease.
Officials emphasised that widening the vaccination scheme is a proactive measure designed to safeguard the community and prevent further spread.
Outbreak Details and Patient Demographics
The UKHSA has released further details on the outbreak, indicating that the median age of patients is 19. While the majority are students, five individuals are not enrolled in education. A striking 87% of patients attended Club Chemistry in Canterbury at least once between 5-7 March before falling ill.
Most of those affected were students, and the three cases who did not visit the nightclub are all University of Kent students residing in halls of residence with connections to attendees. The earliest known case became unwell on 9 March, with the latest reported on 16 March. The peak of the outbreak occurred on 13 March, when the largest number of cases was recorded.
Bacterial Strain Analysis and Treatment Efficacy
Last week, officials confirmed that the outbreak is caused by a strain belonging to group B meningococci, with a recently emerged subtype that has been present in England since 2020. However, the UKHSA suspects the bacteria's genome exhibits "multiple potentially significant genetic differences" compared to closely related genomes.
These genetic variations are currently being evaluated to understand how they might alter the bacteria's behaviour. Importantly, agency analysis has shown that the strain responds effectively to both antibiotics and the existing meningitis B vaccine.
Expert Reassurance and Ongoing Investigations
Professor Robin May, Chief Scientific Officer at UKHSA, stated: "This preliminary analysis offers strong reassurance that our existing vaccinations and antibiotic treatment will be effective against this strain. In collaboration with the research community, we will continue intensive laboratory investigations to determine how factors such as the bacterial strain, social or environmental conditions, and population immunity may have influenced the outbreak's spread."
All patients in the Kent outbreak have required hospital admission, with nine admitted to intensive care units, where four remain. Tragically, two students have died: 18-year-old Juliette Kenny, described by her family as "fit, healthy and strong" prior to her death, and another University of Kent student.
The expansion of the vaccination programme to Year 11 pupils underscores the ongoing efforts to contain the outbreak and protect vulnerable populations through evidence-based public health interventions.
